The Advocacy Training Session

 

The first training for certification will include a
variety of topics to give advocates a well-grounded understanding of
methadone treatment, research, regulations and laws that protect
methadone patients and programs.

 

  1. Addiction
    and Methadone
    Tom Payte, MD (Drug Dependence
    Associates) and Joycelyn Woods, MA. (NAMA) The
    biological constructs of addiction will be explained in a way that
    can be understood by lay people (i.e. opiate receptors, Endorphins)
    Methadone dose and what is considered an adequate dose and why it is
    important and what methadone does to make you feel normal.
  2. Regulations
    and Accreditatio
    n
    C. Todd
    Rosendale (CSAT/DPT), Sharon Dow (Joint Commission), Bettye Harrison
    (CARF) and Joanne Page (COA).The new federal regulations will be explained:  What
    they are and how they relate to the state regulations? Accreditation
    and what an accreditation survey is, how it is done, and how
    advocates can be involved.
  3. The
    Different Faces of Advocacy

    Presenters to be announced.
    Advocates from around the country will explain what they do to
    advance the goals of methadone advocacy. This session will also
    explain the different types of advocacy that advocates are involved
    in.
  4. How
    to End Methadone Stigma
    Herman Joseph, Ph.D. The history of
    methadone stigma will be presented and how it has impacted methadone
    treatment and the recipients of it. A plan for advocates to work on
    for ending it will be revealed.
  5. Advocate
    Certification

    Walter Ginter (NAMA Training and Certification Director) What is certification and how it
    will professionalize those committed to methadone advocacy.  The Advocates Code of Ethics, the Goals of Methadone
    Advocacy, and Advocate Certification.

         Top

Similar Posts

  • The National Methadone Conference-3

    Admin 05/13/2023

    American Association for the Treatment of Opioid Dependence Washington, D.C. ~ April 13-16, 2003 Session: Organizational Meeting April 15, 2003 Picture Essay of NAMA’s Organizational Meeting Starting the Meeting Joyce calls the meeting to order. Top (l-r) Robert Sanders (NYC NAMA), Becki Ballard (OK NAMA), Gary Nessenbaum (WAMM), Jennifer Nelson Connelly (PA NAMA), Joycelyn Woods,…

  • Focus On

    Admin 09/16/2021

    Issues To Focus On LAAM Manufacture to Be Discontinued August 23, 2003 Washington, D.C. Roxanne the manufacturer of LAAM has informed the FDA that manufacture of the medication is being discontinued. Distribution will continue until the inventory is depleted. Roxanne estimates this to be in early January 2004. The reason for the action is the…

  • Pre-conference Meeting Sunday, October 7th Unifying the Treatment Community

    Admin 01/11/2022

    Unifying the Treatment Community This special pre-conference meeting is divided into two sessions – a morning and afternoon session. These sessions have been developed by the Advocacy Coalition: National Alliance of Methadone Advocates (NAMA), Advocates for Recovery through Medicine (ARM), Advocates For the Integration of Recovery and Methadone (AFIRM), Virginia Alliance of Methadone Advocates (VAMA),…

  • At ATTOD

    Admin 02/19/2022

    Methadone Advocate Training   Want to know what a Methadone Conference is like? Check out our report on the NAMA website methadone.org                         FIRST EVER METHADONE (MAT) ADVOCATE TRAINING AND CERTIFICATION AT THE 2003 AATOD CONFERENCE IN Washington, DC SATURDAY APRIL 12, 2003 Information about the first ever CMA Training at AATOD on April 12,…

  • NAMA SITE SEARCH

    Admin 04/08/2022

    Search the NAMA site with Digital Equipment Corporation’s excellent ALTAVISTA search engine! Just type your search term(s) next to the text Reading “url:Methadone.org” Search for:    NOTE: This search takes you away from our site. Either use your browser’s “Back” button or choose one of the results returned by AltaVista to continue with us.  

  • Tag: ADA

    Admin 12/09/2022

    DOJ publishes guidance on Opioid Use Disorder and the Americans with Disabilities Act April 15, 2022 “The opioid crisis poses an extraordinary challenge to communities throughout our country. The Department of Justice (the Department) has responded with a comprehensive approach prioritizing prevention, enforcement, and treatment. This includes enforcing the Americans with Disabilities Act (Ada), which…